PPD was named Best CRO Provider at the sixth-annual World ADC Awards, according to a news release.

The awards, which recognize distinction within antibody-drug conjugate (ADC) research, were held in October in conjunction with the 10th annual World ADC San Diego Conference.

Pharmaceutical Product Development LLC (PPD), a global contract research organization (CRO), was named Best CRO Provider for the second time in the past three years at the awards, officials said in the release.

The award recognizes the firm's PPD Laboratories professionals in helping advance clients’ ADC research to develop new anticancer therapies.
 
"ADCs are complex biotherapeutic molecules that combine monoclonal antibodies with an attached payload of highly potent cytotoxic drugs. They are designed to target and destroy cancer tumor cells with high specificity and efficiency, while minimally impacting healthy cells," officials said in the release.
 
PPD Laboratories has offered services assisting ADC development since 2009. PPD’s immunochemistry department supports more than 57 ADC methods and the chromatography department supports over 150 methods, stated the release.
 
"In oncology, PPD Laboratories performed the bioanalysis on five of the six ADCs currently approved by the FDA and helped develop 19 of the 20 top-selling cancer therapies of 2018," stated the release.

PPD Laboratories also provides chemistry, manufacturing and control analytical method development/validation and testing for ADC products.